1
|
Joseph JM, Gigliobianco MR, Firouzabadi BM, Censi R, Di Martino P. Nanotechnology as a Versatile Tool for 19F-MRI Agent's Formulation: A Glimpse into the Use of Perfluorinated and Fluorinated Compounds in Nanoparticles. Pharmaceutics 2022; 14:382. [PMID: 35214114 PMCID: PMC8874484 DOI: 10.3390/pharmaceutics14020382] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2021] [Revised: 01/28/2022] [Accepted: 02/02/2022] [Indexed: 02/04/2023] Open
Abstract
Simultaneously being a non-radiative and non-invasive technique makes magnetic resonance imaging (MRI) one of the highly sought imaging techniques for the early diagnosis and treatment of diseases. Despite more than four decades of research on finding a suitable imaging agent from fluorine for clinical applications, it still lingers as a challenge to get the regulatory approval compared to its hydrogen counterpart. The pertinent hurdle is the simultaneous intrinsic hydrophobicity and lipophobicity of fluorine and its derivatives that make them insoluble in any liquids, strongly limiting their application in areas such as targeted delivery. A blossoming technique to circumvent the unfavorable physicochemical characteristics of perfluorocarbon compounds (PFCs) and guarantee a high local concentration of fluorine in the desired body part is to encapsulate them in nanosystems. In this review, we will be emphasizing different types of nanocarrier systems studied to encapsulate various PFCs and fluorinated compounds, headway to be applied as a contrast agent (CA) in fluorine-19 MRI (19F MRI). We would also scrutinize, especially from studies over the last decade, the different types of PFCs and their specific applications and limitations concerning the nanoparticle (NP) system used to encapsulate them. A critical evaluation for future opportunities would be speculated.
Collapse
Affiliation(s)
- Joice Maria Joseph
- School of Pharmacy, University of Camerino, 62032 Camerino, Italy; (J.M.J.); (B.M.F.); (P.D.M.)
| | | | | | - Roberta Censi
- School of Pharmacy, University of Camerino, 62032 Camerino, Italy; (J.M.J.); (B.M.F.); (P.D.M.)
| | - Piera Di Martino
- School of Pharmacy, University of Camerino, 62032 Camerino, Italy; (J.M.J.); (B.M.F.); (P.D.M.)
- Dipartimento di Farmacia, Università “G. D’Annunzio” Chieti e Pescara, 66100 Chieti, Italy
| |
Collapse
|
4
|
Hutin A, Lidouren F, Kohlhauer M, Lotteau L, Seemann A, Mongardon N, Renaud B, Isabey D, Carli P, Vivien B, Ricard JD, Hauet T, Kerber RE, Berdeaux A, Ghaleh B, Tissier R. Total liquid ventilation offers ultra-fast and whole-body cooling in large animals in physiological conditions and during cardiac arrest. Resuscitation 2015; 93:69-73. [PMID: 26070832 DOI: 10.1016/j.resuscitation.2015.05.020] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2015] [Revised: 04/19/2015] [Accepted: 05/21/2015] [Indexed: 10/23/2022]
Abstract
INTRODUCTION Total liquid ventilation (TLV) can cool down the entire body within 10-15 min in small animals. Our goal was to determine whether it could also induce ultra-fast and whole-body cooling in large animals using a specifically dedicated liquid ventilator. Cooling efficiency was evaluated under physiological conditions (beating-heart) and during cardiac arrest with automated chest compressions (CC, intra-arrest). METHODS In a first set of experiments, beating-heart pigs were randomly submitted to conventional mechanical ventilation or hypothermic TLV with perfluoro-N-octane (between 15 and 32 °C). In a second set of experiments, pigs were submitted to ventricular fibrillation and CC. One group underwent continuous CC with asynchronous conventional ventilation (Control group). The other group was switched to TLV while pursuing CC for the investigation of cooling capacities and potential effects on cardiac massage efficiency. RESULTS Under physiological conditions, TLV significantly decreased the entire body temperatures below 34 °C within only 10 min. As examples, cooling rates averaged 0.54 and 0.94 °C/min in rectum and esophageous, respectively. During cardiac arrest, TLV did not alter CC efficiency and cooled the entire body below 34 °C within 20 min, the low-flow period slowing cooling during CC. CONCLUSION Using a specifically designed liquid ventilator, TLV induced a very rapid cooling of the entire body in large animals. This was confirmed in both physiological conditions and during cardiac arrest with CC. TLV could be relevant for ultra-rapid cooling independently of body weight.
Collapse
Affiliation(s)
- Alice Hutin
- Inserm, U955, Equipe 03, F-94000 Créteil, France; Université Paris Est, UMR_S955, DHU A-TVB, UPEC, F-94000 Créteil, France; Université Paris Est, Ecole Nationale Vétérinaire d'Alfort, F-94700 Maisons-Alfort, France; Hôpitaux Universitaires Paris Centre, Cochin Hôtel-Dieu, Université Paris Descartes - Paris V , F-75014 Paris France
| | - Fanny Lidouren
- Inserm, U955, Equipe 03, F-94000 Créteil, France; Université Paris Est, UMR_S955, DHU A-TVB, UPEC, F-94000 Créteil, France; Université Paris Est, Ecole Nationale Vétérinaire d'Alfort, F-94700 Maisons-Alfort, France
| | - Matthias Kohlhauer
- Inserm, U955, Equipe 03, F-94000 Créteil, France; Université Paris Est, UMR_S955, DHU A-TVB, UPEC, F-94000 Créteil, France; Université Paris Est, Ecole Nationale Vétérinaire d'Alfort, F-94700 Maisons-Alfort, France
| | - Luc Lotteau
- Bertin Technologies, Montigny le Bretonneux F-78180, France
| | - Aurélien Seemann
- Inserm, U955, Equipe 03, F-94000 Créteil, France; Université Paris Est, UMR_S955, DHU A-TVB, UPEC, F-94000 Créteil, France; Université Paris Est, Ecole Nationale Vétérinaire d'Alfort, F-94700 Maisons-Alfort, France
| | - Nicolas Mongardon
- Inserm, U955, Equipe 03, F-94000 Créteil, France; Université Paris Est, UMR_S955, DHU A-TVB, UPEC, F-94000 Créteil, France; Université Paris Est, Ecole Nationale Vétérinaire d'Alfort, F-94700 Maisons-Alfort, France
| | - Bertrand Renaud
- Hôpitaux Universitaires Paris Centre, Cochin Hôtel-Dieu, Université Paris Descartes - Paris V , F-75014 Paris France
| | - Daniel Isabey
- Université Paris Est, UMR_S955, DHU A-TVB, UPEC, F-94000 Créteil, France; Inserm, U955, Equipe 13, F-94000 Créteil, France
| | - Pierre Carli
- SAMU de Paris, Département d'Anesthésie Réanimation, Hôpital Universitaire Necker-Enfants Malades, Université Paris Descartes - Paris V, F-75015 Paris, France
| | - Benoit Vivien
- SAMU de Paris, Département d'Anesthésie Réanimation, Hôpital Universitaire Necker-Enfants Malades, Université Paris Descartes - Paris V, F-75015 Paris, France
| | - Jean-Damien Ricard
- Inserm, IAME, 1137, Univ Paris Diderot, Sorbonne Paris Cité, F-75018 Paris, France; Assistance Publique - Hôpitaux de Paris, Hôpital Louis Mourier, Service de Réanimation Médico-chirurgicale, F-92700 Colombes, France
| | | | - Richard E Kerber
- Department of Internal Medicine, Division of Cardiovascular Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA
| | - Alain Berdeaux
- Inserm, U955, Equipe 03, F-94000 Créteil, France; Université Paris Est, UMR_S955, DHU A-TVB, UPEC, F-94000 Créteil, France; Université Paris Est, Ecole Nationale Vétérinaire d'Alfort, F-94700 Maisons-Alfort, France
| | - Bijan Ghaleh
- Inserm, U955, Equipe 03, F-94000 Créteil, France; Université Paris Est, UMR_S955, DHU A-TVB, UPEC, F-94000 Créteil, France; Université Paris Est, Ecole Nationale Vétérinaire d'Alfort, F-94700 Maisons-Alfort, France
| | - Renaud Tissier
- Inserm, U955, Equipe 03, F-94000 Créteil, France; Université Paris Est, UMR_S955, DHU A-TVB, UPEC, F-94000 Créteil, France; Université Paris Est, Ecole Nationale Vétérinaire d'Alfort, F-94700 Maisons-Alfort, France.
| |
Collapse
|